USPTO serial 79070126
BIONORICA
Reviewed by CopyMark Law Group
Reg. 3870253Status 706Registered
- Filing date
- Status date
- Registration date
- Nov 2, 2010
- Examiner
- LOTT, MAUREEN DALL
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with BIONORICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
92318 Neumarkt, DE
92318 Neumarkt, DE
Neumarkt, DE
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KENNETH F. FLOREK
KENNETH F. FLOREK FLOREK & ENDRES PLLC552 Seventh Avenue, Suite 601NEW YORK, NY 10018UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | [ Essential oils for use in the manufacture of cosmetics, hair lotions and perfumery; hair lotions; dentifrices ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of [ gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, ] angina, [ atherosclerosis, ] bronchial asthma, [ circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, ] inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, [ arthritis, osteoarthritis, ] fever, cough, cold, [ Alzheimer's disease, ] infection of respiratory tract, [ infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; ] pharmaceutical preparations for sensory organs, namely, for use in [ ophthalmology, ] otolaryngology [ and dermatology] ; pharmaceutical preparations for regulation and strengthening of the immune system, [ pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays, ] plant extracts for [ veterinary and ] pharmaceutical purposes; [ sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for health purposes; medicated sanitary preparations for the treatment, cleaning and protection of the skin; ] dietary supplements in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form, containing plant extracts; dietetic foods adapted for medical use in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ food for medically restricted diets, food for diabetics, ] food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, [ drops, capsules, ] extract preparations, balms or in liquid form; [ vitamin and mineral supplements; food and food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for use in foods and dietary supplements for human consumption; ] dietetic food supplements, dietary supplements, food supplements and dietary food supplements; [ mineral food supplements, food supplements based on amino acids, minerals and/or trace elements, medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants, material for stopping teeth; dental wax ] | ACTIVE | — |
| 016 | [ Paper; cardboard; goods made from paper and cardboard, namely, paper bags, coasters, and works of art in the nature of art prints; printed matter, namely, books, magazines, journals, newspapers, periodicals, leaflets, manuals, catalogs and brochures in the fields of health and medicine; printed reviews in the nature of a series of written articles in the fields of health and medicine; bookbinding material, namely, book bindings; photographs; stationery; adhesives for stationery or household purposes; artists' materials, namely, artists' pastels, artists' pencils, artists' pens, painting sets for children; paint brushes; typewriters; office requisites except furniture, namely, punches, staplers, erasers, desk pads, pencil sharpeners; instructional and teaching material, namely, printed instructional and teaching material in the field of medicine and phytopharmacy; paper bags, envelopes and pouches for packaging, plastic bags and bubble packs for packaging ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica AG
- Other trademarks owned by Bionorica SE
- Other trademarks owned by Bionorica SE
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 016
- Similar marks named BIONORICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 18, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 9, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 22, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 17, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 1, 2021 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Aug 15, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 15, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 15, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Dec 9, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 16, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 2, 2019 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 11, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 11, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 7, 2017 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 7, 2017 | INPC | INVALIDATION PROCESSED | — |
| Nov 29, 2017 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 29, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 29, 2017 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Mar 28, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 12, 2016 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 12, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 11, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 11, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 2, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 2, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2010 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 17, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 12, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 12, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jul 9, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 14, 2010 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 14, 2010 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 14, 2010 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 7, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 29, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2010 | ALIE | ASSIGNED TO LIE | — |
| May 12, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 14, 2010 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Apr 13, 2010 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Mar 26, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 26, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 26, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2010 | FAXX | FAX RECEIVED | — |
| Mar 23, 2010 | FAXX | FAX RECEIVED | — |
| Feb 26, 2010 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Feb 26, 2010 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Feb 26, 2010 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 26, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jan 25, 2010 | PAPER RECEIVED | — | |
| Oct 3, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 3, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 3, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 1, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 31, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 24, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 24, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Jul 23, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |